BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arora Z, Mukewar S, Wu X, Shen B. Risk factors and clinical implication of superimposed Campylobacter jejuni infection in patients with underlying ulcerative colitis. Gastroenterol Rep (Oxf). 2016;4:287-292. [PMID: 26159630 DOI: 10.1093/gastro/gov029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Korchagina AA, Koroleva E, Tumanov AV. Innate Lymphoid Cells in Response to Intracellular Pathogens: Protection Versus Immunopathology. Front Cell Infect Microbiol 2021;11:775554. [PMID: 34938670 DOI: 10.3389/fcimb.2021.775554] [Reference Citation Analysis]
2 Axelrad JE, Joelson A, Green PHR, Lawlor G, Lichtiger S, Cadwell K, Lebwohl B. Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel Disease. Am J Gastroenterol. 2018;113:1530-1539. [PMID: 30072777 DOI: 10.1038/s41395-018-0211-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
3 Axelrad JE, Cadwell KH, Colombel JF, Shah SC. The role of gastrointestinal pathogens in inflammatory bowel disease: a systematic review. Therap Adv Gastroenterol 2021;14:17562848211004493. [PMID: 33868457 DOI: 10.1177/17562848211004493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Chandra N, Srivastava A, Kumar S. Bacterial biofilms in human gastrointestinal tract: An intricate balance between health and inflammatory bowel diseases. World J Pharmacol 2019; 8(3): 26-40 [DOI: 10.5497/wjp.v8.i3.26] [Cited by in CrossRef: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Harvala H, Rosendal T, Lahti E, Engvall EO, Brytting M, Wallensten A, Lindberg A. Epidemiology of Campylobacter jejuni infections in Sweden, November 2011-October 2012: is the severity of infection associated with C. jejuni sequence type? Infect Ecol Epidemiol 2016;6:31079. [PMID: 27059819 DOI: 10.3402/iee.v6.31079] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
6 Singh A, Ashburn J, Kochhar G, Lopez R, Hull TL, Shen B. Value of routine stool testing for pathogenic bacteria in the evaluation of symptomatic patients with ileal pouches. Gastroenterol Rep (Oxf) 2018;6:93-100. [PMID: 29780596 DOI: 10.1093/gastro/gox037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
7 Heimesaat MM, Genger C, Biesemeier N, Klove S, Weschka D, Mousavi S, Bereswill S. Inflammatory Immune Responses and Gut Microbiota Changes Following Campylobacter coli Infection of IL-10-/- Mice with Chronic Colitis. Pathogens 2020;9:E560. [PMID: 32664563 DOI: 10.3390/pathogens9070560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Jing X, Korchagina AA, Shein SA, Muraoka WT, Koroleva E, Tumanov AV. IL-23 Contributes to Campylobacter jejuni-Induced Intestinal Pathology via Promoting IL-17 and IFNγ Responses by Innate Lymphoid Cells. Front Immunol 2020;11:579615. [PMID: 33488580 DOI: 10.3389/fimmu.2020.579615] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Iguidbashian JP, Parekh JD, Kukrety S, Andukuri VG. Campylobacter jejuni and Pseudomonas coinfection in the setting of ulcerative colitis. BMJ Case Rep 2018;2018:bcr-2018-224941. [PMID: 29880626 DOI: 10.1136/bcr-2018-224941] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]